News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2018 Shelley Wood October 31, 2018
News Daily News Statin Benefits: Yes for CVD but No for Everything Else, Says New Review Michael O'Riordan October 08, 2018
News Daily News SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function Todd Neale July 02, 2018
News Conference News ACC 2018 Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS Michael O'Riordan March 12, 2018
News Daily News Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR Shelley Wood October 16, 2017
News Daily News CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition Michael O'Riordan August 04, 2017
Presentation Association Between CKD and Outcomes With Use of Prasugrel vs Clopidogrel in PCI for ACS August 04, 2017
Presentation TCT 2016 PCI Pharmacotherapy Considerations in Patients With Complicating Co-morbidities (CKD, Liver Disease, ASA Allergy, Prior Stroke, Thrombocytopenia) Presenter: Sorin J. Brener, Franz-Josef Neumann, Sunil V. Rao October 30, 2016
News Industry News Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin August 25, 2016
News Daily News Más de la Mitad de los Estudios sobre ECV Excluyen a Pacientes con Enfermedad Renal Michael O'Riordan December 03, 2015
News Daily News Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease L.A. McKeown September 28, 2015
News Industry News Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease August 14, 2015
News Daily News El Método Elegido para Calcular la Función Renal Pre-PCI es Relevante L.A. McKeown June 29, 2015
Presentation Choice of eGFR Equation Impacts Drug-Dosing Recommendations and Risk Stratification in CKD Patients Undergoing PCI Presenter: J. Parsh June 26, 2015